Robert Lim - Concepedia

Author

Robert Lim

National University Hospital

Also Known As

Lim, R.S., R Lim, R. Lim, R. S. Lim, R.S. Lim, R.S.C. Lim, Remington Lim, Robert Lim, Robert Lim, MD, Robert S. C. Lim

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

National University Hospital University of Ottawa Ottawa Hospital Chinese University of Hong Kong Prince of Wales Hospital

About

Robert Lim is an author at National University Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	263
2	Health Sciences	2	2	51
3	Hepatology	2	2	78
4	Engineering	1	1	19
5	Gastroenterology	1	1	18

Robert Lim

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Malcolm J. Moore, David Goldstein, John Hamm, Journal of Clinical Oncology	2007	3.8K
The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts Marta Chesi, Elena Nardini, Robert Lim, Blood	1998	550
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Malcolm J. Moore, David Goldstein, John Hamm, Journal of Clinical Oncology	2023	272
Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group Winnie Yeo, Hyun Cheol Chung, Stephen L. Chan, Journal of Clinical Oncology	2012	188
Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial Alfredo Carrato, Anna Świeboda-Sadlej, Marzanna Staszewska-Skurczyńska, Journal of Clinical Oncology	2013	132
Pharmacogenetics of SLCO1B1 gene and the impact of 1b and 15 haplotypes on irinotecan disposition in Asian cancer patients Xiaoqiang Xiang, Srinivasa Rao Jada, Hui Hua Li, Pharmacogenetics and Genomics	2006	91
Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre R. Rajaratnam, C. Mann, P. Balasubramaniam, Clinical and Experimental Dermatology	2010	88
Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies Chiung‐Ing Wong, Tong-San Koh, Ross A. Soo, Journal of Clinical Oncology	2009	83
Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer Satheesh Krishna, Christopher S. Lim, Matthew D. F. McInnes, Journal of Magnetic Resonance Imaging	2017	75
Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib Andrea Li Ann Wong, Joline S.J. Lim, Arvind Sinha, Journal of Translational Medicine	2015	74

Page 1